Control Pre-treatment Post-treatment
Glucose mg/dl 93.562 ± 18.402 102.70 ± 19.562 112.600 ± 39.044
TP g/l 75.75 ± 8.434 69.40 ± 7.904 79.30 ± 11.005b
Urea mg/dl 32.6 ± 10.9 32.9 ± 9.3 40.6 ± 13.0
Creatinine mg/dl 1.113 ± 0.255 1.110 ± 0.218 1.253 ± 0.143
TC mg/dl 191.437 ± 34.298 189.00 ± 70.63 215.40 ± 84.417
TG mg/dl 123.06 ± 32.947 167.70 ± 49.349a 189.80 ± 41.651c
AST U/I 22.937 ± 6.884 23.40 ± 9.395 30.00 ± 8.856c
ALT U/I 18.375 ± 6.365 16.20 ± 8.495 23.20 ± 14.195
LDH U/I 130.50 ± 33.091 142.70 ± 31.478 169.20 ± 28.389c
CK IU/I 131.75 ± 33.914 100.50 ± 36.427a 120.50 ± 53.435
Non-significant (p>0.05), significant (p<0.05)
aControl with pre-treatment
bPre-treatment with post-treatment
cControl with post-treatment
TP: Total Protein; TC: Total Cholesterol; TG: Triglyceride; AST: Aspartate Transaminase; ALT: Alanine Transaminase; LDH: Lactate Dehydrogenase; CK: Creatine Kinase
Table 2: In vivo effect of methyldopa on laboratory findings.
Goto home»